Welcome to the website of the UK Chemotherapy Partnership – aiming to improve the quality and safety of chemotherapy delivery by sharing information, expertise and opinion. We open the door on the latest developments in chemotherapy service provision and give you access to NHS experts and their documentation to help you develop and improve your own service.

Chemotherapy service

Chemotherapy delivery can be complex and challenging. These are some of the practice innovations and developments within the UK aiming to improve the patient experience.

March 2016
Events & meetings

UKCP Systemic-Anti Cancer Therapy Masterclass
Programme to follow.  


Coming soon. We are very excited to announce this new online educational resource. It will initially include 6 modules on cancer and chemotherapy.

Our videos

Healthcare professionals sharing experiences of service developments, including patient information videos for patients embarking on the treatment pathway.

What's new

Achieving World-Class Outcomes-A Strategy for England 2015-2020

Five year plan to radically improve cancer outcomes.

2015 ASCO Annual Meeting-Highlights

Highlights from the 2015 ASCO Annual Meeting-Illumination & Innovation; Transforming Data into Learning

Recovery Package-Cancer Nursing Partnership

The CNP is working to roll out the Recovery Package

Understanding Cancer E-Learning

Understanding Cancer was launched in April 2012.


Latest news

FDA approves bevacizumab with chemotherapy for platinum-sensitive ovarian cancer

The U.S. Food and Drug Administration (FDA) has approved bevacizumab, either in combination with carboplatin and paclitaxel or in combination with carboplatin and gemcitabine chemotherapy, followed by bevacizumab alone, for the treatment of patients with...

Personalised cancer vaccine associated with promising outcomes for AML patients

A personalised cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukaemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center (BIDMC). The product...

Fat intake shows link to metastasis

The discovery of metastasis-promoting protein receptors (CD36) in mouse cells has led to the launch of a new drug development initiative, reports a study published in Nature. The Spanish researchers furthermore demonstrated that the CD36 metastatic...

SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive breast cancer

Progression-free survival was more than doubled for patients with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer resistant to aromatase inhibitor therapy by adding everolimus (Afinitor) to treatment with the endocrine therapeutic...

SABCS 2016 : Adding veliparib to chemotherapy improved response rates among patients with BRCA-mutant breast cancer

Adding the investigational poly(ADP-ribose) polymerase (PARP) inhibitor veliparib to carboplatin and paclitaxel chemotherapy improved the overall response rate without increasing adverse events among patients who had locally recurrent or metastatic breast...